SUBSCRIBE
SUBSCRIBE
News   Business

Kos Pharmaceuticals To Report Third Quarter Results On November 9, 2006 Conference Call At 8:30 A.M. ET

November 3, 2006 | 
1 min read
CRANBURY, N.J.--(BUSINESS WIRE)--Kos Pharmaceuticals, Inc. (Nasdaq:KOSP), a fully integrated specialty pharmaceutical company, will announce results for the third quarter ended September 30, 2006, before the market opens on Thursday, November 9, 2006.
Earnings
MORE ON THIS TOPIC
People are attracted to a profitable business. Corporation, joint venture. Fundraising. Fair distribution of income among team members. Development of funds, budget use. Investment groups. Corruption
Radiopharmaceuticals
Actithera Raises $75.5M To Play in Sizzling Radiopharma Space
July 9, 2025
 · 
2 min read
 · 
Tristan Manalac
Solution Concept with Handshake on Chalkboard Background
Mergers & acquisitions
Concentra Snags Another Struggling Biotech as Cargo Accepts $200M Buyout
July 8, 2025
 · 
1 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
CSL Trims Research and Development Unit
July 8, 2025
 · 
152 min read
 · 
BioSpace Editorial Staff
Robot and human hand in retro collage style with halftone. Vector illustration, artificial intelligence concept.
Artificial intelligence
Roche’s Chugai Breaks Into Aging via Potential $1B+ Deal With AI Outfit Gero
July 7, 2025
 · 
2 min read
 · 
Dan Samorodnitsky